
Piles vs Fissure vs Fistula: How to Know the Difference
- 16-09-2026
- Article

When does a thyroid nodule need FNAC? Learn FNAC size criteria for TI-RADS 3, 4 and 5 nodules, suspicious ultrasound features and what happens after biopsy.
If an ultrasound has detected a thyroid nodule, one of the first questions patients usually ask me is, “Doctor, do I need an FNAC?”
The answer is not based on the presence of a thyroid nodule alone.
Most thyroid nodules are benign, and many small nodules can be safely monitored without biopsy. FNAC is usually considered when the nodule reaches a particular size, has suspicious ultrasound features, or when the patient's clinical history raises additional concern.
The aim is to biopsy the nodules that genuinely need further evaluation while avoiding unnecessary procedures for nodules that can safely be followed.
FNAC stands for Fine-Needle Aspiration Cytology. It is also commonly referred to as FNA or fine-needle aspiration biopsy.
During the procedure, a very thin needle is inserted into the thyroid nodule, usually under ultrasound guidance. A small sample of cells is collected and sent to the laboratory for examination.
The purpose of FNAC is to help determine whether the thyroid nodule is benign, suspicious, indeterminate or malignant.
No.
This is one of the most important points I explain to patients.
Finding a thyroid nodule on ultrasound does not automatically mean that a biopsy is necessary.
The decision usually depends on:
Ultrasound tells us much more than simply the size of a thyroid nodule.
It allows the radiologist to assess:
These features help determine how suspicious a nodule appears and whether FNAC is necessary.
TI-RADS stands for Thyroid Imaging Reporting and Data System.
It is a structured system used to classify thyroid nodules according to their ultrasound appearance.
Under the commonly used ACR TI-RADS system:
The higher the category, the more suspicious the ultrasound features. However, TI-RADS is a risk classification and not a diagnosis of thyroid cancer.
A TR3 thyroid nodule is considered mildly suspicious.
Under ACR TI-RADS recommendations:
Therefore, a small TR3 thyroid nodule does not usually need immediate FNAC simply because it exists.
A TR4 thyroid nodule is considered moderately suspicious.
Under ACR TI-RADS:
A TR4 result should therefore be interpreted together with the actual nodule size.
A 7 mm TR4 nodule and a 2 cm TR4 nodule do not automatically receive the same management.
TR5 means the nodule has ultrasound features considered highly suspicious.
Under ACR TI-RADS:
TR5 does not mean that cancer has already been confirmed. It means that the nodule deserves closer evaluation.
| ACR TI-RADS Category | Risk Category | Follow-Up Threshold | FNAC Threshold |
|---|---|---|---|
| TR3 | Mildly suspicious | ?1.5 cm | ?2.5 cm |
| TR4 | Moderately suspicious | ?1.0 cm | ?1.5 cm |
| TR5 | Highly suspicious | ?0.5 cm | ?1.0 cm |
These are guideline thresholds and should not be used as a substitute for an individual clinical assessment. Other thyroid guidelines may use somewhat different criteria.
Certain ultrasound findings contribute to a higher TI-RADS score.
Features that may raise concern include:
No single feature should usually be interpreted in isolation. The overall ultrasound pattern and nodule size are considered together.
Not simply because it is large.
A nodule's ultrasound pattern remains important.
For example, a larger mildly suspicious nodule may reach the biopsy threshold, while a purely benign-appearing cystic nodule may be managed differently.
This is why using size alone to decide whether a thyroid nodule is dangerous can be misleading.
Yes, in selected situations.
Although standard TI-RADS thresholds help avoid unnecessary biopsy of very small nodules, doctors may sometimes recommend further evaluation when there are additional concerning factors.
Examples may include:
The complete clinical picture matters more than any single number on the ultrasound report.
Growth deserves reassessment, but growth alone does not prove that a thyroid nodule is cancerous.
A benign nodule can increase in size over time.
If a nodule grows significantly, we usually review:
The nodule may then meet the criteria for FNAC even if it did not require biopsy during the previous scan.
A visible neck swelling should be properly evaluated, but it does not automatically mean that FNAC is necessary.
Ultrasound is usually the first step in understanding the swelling.
If ultrasound confirms a thyroid nodule, its size and imaging characteristics help determine whether FNAC is appropriate.
Large thyroid nodules can occasionally produce pressure symptoms such as:
These symptoms are important even when the nodule appears benign.
A benign nodule may still require treatment if it is large enough to cause significant pressure or cosmetic concerns.
Persistent or unexplained voice change associated with a thyroid nodule deserves medical evaluation.
Voice changes can occur for many reasons unrelated to thyroid cancer, but when a persistent change occurs together with a thyroid swelling, it should not be ignored.
No.
Thyroid blood tests and thyroid nodule evaluation answer different questions.
Tests such as TSH, T3 and T4 tell us how the thyroid gland is functioning.
Ultrasound and FNAC help us evaluate the structure and cellular nature of the thyroid nodule.
A patient can have completely normal thyroid hormone levels and still have a nodule that meets criteria for FNAC.
If TSH is suppressed, the doctor may sometimes recommend additional evaluation to determine whether the nodule is producing excess thyroid hormone.
A thyroid nuclear scan may be useful in this situation.
Hyperfunctioning or “hot” nodules are generally evaluated differently from non-functioning nodules, so the biopsy decision should be individualized.
FNAC is usually performed under ultrasound guidance.
The patient lies on the examination table with the neck gently extended.
After identifying the nodule with ultrasound, a very thin needle is guided into the targeted area and cells are collected.
More than one sample may be taken to improve diagnostic accuracy.
The samples are then examined by a cytopathologist.
Most patients tolerate thyroid FNAC well.
You may feel a brief needle prick or pressure in the neck during sampling.
Mild tenderness or bruising may occur afterward, but significant complications are uncommon.
Because the procedure is usually ultrasound-guided, the doctor can accurately target the thyroid nodule.
The laboratory examines the collected cells and reports the findings.
Results are often categorized using the Bethesda System.
The result may be:
The next step depends on the Bethesda category, ultrasound appearance and individual clinical situation.
A benign FNAC result is reassuring.
Many patients then require only ultrasound follow-up rather than surgery.
However, treatment may still be considered if a benign thyroid nodule:
Yes, in appropriately selected patients.
A confirmed benign thyroid nodule causing symptoms may sometimes be treated with minimally invasive techniques such as radiofrequency ablation or microwave ablation.
These procedures use ultrasound guidance to deliver controlled thermal energy into the nodule.
The treated nodule gradually reduces in volume while much of the surrounding normal thyroid tissue is preserved.
Internal link: Link “thyroid nodule ablation” to your Thyroid Nodules Treatment page.
For a nodule being considered for benign thyroid ablation, confirming that the lesion is suitable for a benign treatment pathway is important.
The exact pre-ablation work-up depends on the ultrasound findings, clinical history and treatment protocol.
Patients should not undergo ablation simply because the nodule is large or symptomatic without first completing an appropriate diagnostic assessment.
No.
FNAC is a diagnostic procedure used to obtain cells from the thyroid nodule.
It does not remove the thyroid gland or the entire thyroid nodule.
Surgery is a treatment and may be recommended when there is confirmed cancer, significant suspicion, certain indeterminate findings, major compressive symptoms or another clinical indication.
You should arrange further evaluation if:
When a patient brings me a thyroid ultrasound report, I do not decide on FNAC simply by looking at the nodule size.
I look at the TI-RADS category, size, ultrasound characteristics, symptoms, previous scans and the patient's clinical history.
A small, low-risk nodule may only need monitoring. A moderately suspicious nodule may need FNAC once it reaches the appropriate size. A highly suspicious nodule deserves closer assessment and may require biopsy at a smaller size threshold.
The purpose of FNAC is not to biopsy every thyroid nodule. It is to biopsy the right thyroid nodule at the right time.
No. Many thyroid nodules can be safely monitored without biopsy. The decision depends mainly on ultrasound features, size and clinical risk factors.
Under ACR TI-RADS, FNAC is generally recommended when a TR3 nodule measures 2.5 cm or larger.
Under ACR TI-RADS, FNAC is generally recommended when a TR4 nodule measures 1.5 cm or larger.
Under ACR TI-RADS, FNAC is generally recommended when a TR5 nodule measures 1 cm or larger.
FNAC provides important cytological information and can identify benign, suspicious and malignant findings. Some results remain indeterminate and may require additional evaluation.
Yes. Benign nodules can grow. Significant growth should be reassessed with ultrasound and occasionally repeat FNAC may be considered.
Routine ultrasound-guided thyroid FNAC is a well-established diagnostic procedure and is widely used to evaluate suspicious thyroid nodules.
Not every thyroid nodule needs FNAC.
The decision is based mainly on the combination of ultrasound appearance, TI-RADS category, nodule size and individual clinical factors.
Under ACR TI-RADS, the usual FNAC thresholds are 2.5 cm for TR3 nodules, 1.5 cm for TR4 nodules and 1 cm for TR5 nodules.
A smaller nodule may sometimes need additional evaluation when other concerning features are present, while many low-risk nodules can be safely monitored.
If your thyroid ultrasound report recommends FNAC, discussing the complete report with a thyroid specialist can help you understand why the biopsy is being recommended and what the next step should be.
